Luisa Fiandra is Researcher and Aggregate Professor in Cytology and Comparative Anatomy at the Department of Earth and Environmental Sciences, University of Milano Bicocca (UNIMIB), Italy, and she is member of the Research Center POLARIS (Particular Matter and Health Risk) and of the Nanotoxicology Laboratory of UNIMIB.
2020 – Research and Assistan Professor in Clinical Biochemmistry at University of Milano Bicocca. Research activity in Nanomedicine; study of the efficiency of biologically active molecules and nanodrugs against tumours and neurodegenerative diseases on advanced 3D cell sytems.
2018 – Researcher and Assistant Professor in Cytology and Comparative Anatomy at University of Milano Bicocca.
2017 – Lab Manager of NanoBioLab, Department of Biotechnology and Biosciences (BtBs), UNIMIB.
2010 – Senior researcher and scientific coordinator of the project “Development of novel nanostructured materials for the diagnosis of breast cancer, inflammatory bowel disease (IBD) and modulation of antiretroviral therapy (HAART) in HIV” (financed by Regione Lombardia), Nanomedicine Unit of the Department of Biomedical and Clinical Sciences L. “Sacco”, University of Milano (UNIMI)
2003 – PhD in Invertebrate Biology; 1998, M.Sc. in Life Sciences, UNIMI.
From 2010 to 2017, LF coordinated pre-clinical studies mainly devoted to the use of nanotechnology for cancer therapy and diagnosis, and for biological barriers overcoming. From 2018 LF is involved in the safety evaluation of different types of nanoproducts by in vitro and in vivo (Zebrafish) assays. Within the current project PROTECT (EU Program H2020), the main area of interest is the safety of metal oxides nanoparticles on 3D in vitro skin models according to standardized protocols (OECD, ISO).
LF is author of 31 publications in peer-reviewed journals.
He is member of the Italian Society for Cardiovascular Research (SIRC), the Italian Physiological Society (SIF), the Scientific Board for the Doctoral School in Life and Health Sciences (Univ of Torino) and the Interuniversity Research Centre on Epistemology and History of Life Sciences- Res Viva (Univ of Rome).
In 1997 he founded the Laboratory of Cellular and Molecular Angiogenesis, and authored more than 100 papers on international Journals. His main research interest is focused on the cellular mechanisms involved in the physiology and patology of the vascular system. He wrote two books and several book reviews in italian, mainly on Evolutionary Physiology and History and Philosophy of Biology.
He attended tens of national and international Congresses and Meetings as invited speaker and chairman and served as reviewer for high impact international journals and research grants.
Since 2011 he is scientific supervisor for University-Industry agreements.
Less recently she also took part in studies regarding the modifications of iron metabolism under conditions of increased erythropoiesis and pathological conditions, such as oxidative stress and inflammation. In the past she studied and described the abnormal expression of iron-related proteins in hereditary hemochromatosis.
Carlo Selmi currently leads the Rheumatology and Clinical Immunology Unit at Humanitas research hospital. At Humanitas he leads a young group of physician scientists with wide research and clinical expertise, including periods working at foreign institutions. The team holds dedicated clinics for rheumatoid arthritis, spondiloarthritis, connective tissue disease with dedicated clinics for systemic sclerosis and systemic lupus erythematosus, and is active in articular ultrasound, videocapillaroscopy, arthrocenthesis and intra-articular injections.
He has coauthored over 300 peer-reviewed publications with a Scopus H index of 55 and a total impact factor exceeding 2000. His research track is dedicated to organ-specific and systemic autoimmune and chronic inflammatory diseases, including the clinical epidemiology and pathogenetic mechanisms of autoimmune liver disease, connective tissue disease (particularly systemic sclerosis), and psoriatic arthritis. His work has been funded by the National Institutes of Health, American Liver Foundation, American Scleroderma Foundation, Italian Ministry of Health, Italian Ministry of Foreign Affairs, and the Lilly Research Foundation.
Francesco Di Pierro
Thanks to his passion for pharmacological, phytotherapeutic and nutritional sciences, Di Pierro’s interest follows the need for rational ideation and scientific development of new products/preparations for the pharmaceutical, nutraceutical and cosmetic sectors, as well as of medical devices with particular regard to the branch of dietary supplements and phytotherapeutic remedies.
After the PhD she started her post-doctoral activity in the Cellular and Molecular Angiogenesis Laboratory at the Department of Life Sciences and Systems Biology, Turin, Italy. Her research focuses on the characterization of the paracrine communication between cells that populate dermal/epidermal interface and sub-cutaneous vasculature. In collaboration with pharmaceutical companies she pays her attention on the characterization of the role of natural alternative strategies during skin alteration (i.e. Androgenetic Alopecia) using in vitro co-culture and tri-culture approaches.
After several years of international research in Italy, UK and France, he joined OxiProteomics in 2015, an innovative technology-driven biotech company in Paris, providing science-based solutions to promote healthy living and healthy aging of human population.
Regenerative medicine has become a major focus after patenting Lipogems technology in 2010 with strong collaborative ties with major world institutions. The focus remains in translational clinical research with thousands of patients treated and followed and teaching courses on Lipogems use worldwide.
- 1983-1989 School of Medicine and Surgery – University of Milan, Italy Medical degree (October 1989)
• 1989-1994 Post-graduate school of Plastic and Reconstructive Surgery – University of Parma – Specialization in Plastic Reconstructive and Aesthetic Surgery (July 1994)
• 1994-1996 Department of Plastic Surgery – Lodi Hospital, Legnano Hospital, Niguarda Hospital Internship and collaboration in research projects and teaching courses
•1996-2004 Post-graduate school of Maxillo-facial surgery – University of Parma Contract Professor (course: surgical anatomy of the face )
• Sept 1996-May 2010 Chief of Plastic Surgery sevice, Department of Maxillo-facial Surgery, San Paolo Hospital Reconstructive surgery of acquired and congenital anomalies of the face and body
• 1999-2003 Post-graduate school of Maxillo-facial surgery Specialization in Maxillo-facial surgery (July 2003)
• 2005-2010 School of Dentistry – University of Florence
Contract Professor (course: plastic and reconstructive surgery of the face)
• Feb 2010-May 2010 Adjunct professor DRI institute – University of Miami
Research on adipose derived mesenchimal stem cell (DRI federation)
• May 2010- Consultant Plastic and Maxillo-facial surgeon in different public and private Institutions and universities
- Head of Istituto image Srl
From 2005 to 2018, we was Director of Regulatory & Compliance of Amgen and European Head of Regulatory Affairs, where he directed the Regulatory activities for Europe. He was Member of the European Senior Regulatory Leadership Team. He was also responsible for communication with regulatory agencies regarding regulatory applications, field alerts, recalls, and inspections to address questions, provide routine updates and promote/develop positive relationships. He was Chairman of the International Digital Committee & Regulatory representative in the Multichannel European Team.
From 1990 to 2005, we was Director of Regulatory Affairs and head of Corporate Regulatory staff. In different Companies he had the possibilities to cover different roles of growing responsibilities link into the definition of world-wide registration strategy for medicinal product, cosmetics and medical devices. Furthermore, he was Regulatory advisor for product under development at a corporate level and special projects (like for example “Wisdom”: an I.T. project aiming to put all the Company on a common net, or a Technical Operations project, working on the rationalisation of the production plants).
Since 2014 she has joined Procos SpA, a subsidiary of the Japanese company, CBC Co. Ltd Group specialized in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), as Business Development & IP Expert. Thanks to her expertise she is in charge for the identification and the evaluation of new business opportunities in the field of generic APIs, by analysing the patents landscape related to each business opportunities, the potential project profitability and identifying strategic alliances. Her duties include also the management of the IP rights owned by Procos SpA.
Marina Gallarate is Associate Professor at the University of Torino since 2001. She received her PhD in Pharmaceutical Chemistry from the University of Turin and she worked as Research Associate at the University of Torino from 1990 to 2001. She is teacher in the Courses ”Tecnologia, Socioeconomia e Legislazione Farmaceutiche I and II“ in the Combined Bachelor and Master -300 ECTS in Pharmacy and in in the Specialization School in Hospital Pharmacy.
After several-year experience in the cosmetic fields, her recent research is focused on advanced pharmaceutical technology, aimed to the development of nano/micro-systems such as micro/nanoemulsions, liposomes, lipid micro/nanoparticles, nanocomposite hydrogels as possible drug delivery systems for different administration routes.
She is author or co-author of almost 100 peer-reviewed research papers on international journals, some Italian patent and of many congress communications.
The scientific activity concerns the Pharmaceutical and Cosmetic Technology. The research addresses the development and characterization of colloidal systems such as nanoemulsions, microemulsions, micellar solutions, liposomes, nanoparticles etc. and their application in pharmaceutical and cosmetic formulations.
Currently she studies thermosensitive microemulsions and solid lipid nanoparticle to be proposed for ocular drug delivery.
She is member of the Department of Drug Science and Technology (University of Turin) and from 2008 to 2011 she teached Cosmetic Product Chemistry in the degree course of Herbal Product (Savigliano, CN). From 2011 she teaches Cosmetic Product Chemistry in the degree course of Pharmacy and from 2013 she teaches Pharmaceutical Technology, Socioeconomics and Legislation in the degree course of Pharmacy.
At the present, she is co-author of 44 peer-reviewed publications in international journals.
Born in Germany yet grown in Italy her personality was shaped from the best of the two cultures: precision and passion. She graduated in pharmacy at the University of Milan where she held a research grant for two years after graduating and co-authored 3 publications. She dreamt about becoming a great researcher that could help “save the world”.
Gabriele then found a job at a pharmaceutical company where she worked at the regulatory affairs department in charge of technical dossiers which didn’t fulfill her professional ambitions. Call it destiny, in 1997 she got a job offer at Intercos to join their creative marketing team and decided to change course as she was in love with makeup from age 12 and it was a world she could understand.
Having a background in chemistry, Gabriele quickly got involved more and more with the lab dividing her time between marketing and formulation developing winning products that enriched the company’s portfolio and increase the business.
Surely after a few years she became manager of the applied research lab. Being always curious and in search for innovation she collaborated also with the exploratory research and blue sky labs helping shape and grow what ten years later would be hers. In 2011 Gabriele became R&I Director leading the innovation laboratories in Italy, China, Korea, Brazil and USA. Since 2016 Gabriele is in charge of R&D Make up Global Sr. VP – Corporate Exploratory Research – Applied Research – Regulatory Affairs – Corporate Color Development Intercos SPA.
She is also a lecturer at the Master in Cosmetics offered by the University of Milan, enthusiast horticulturist and loving wife and mom.
at the IRCCS Humanitas Research Hospital.
She currently works in a healthcare communication agency and collaborates with several publishers. In her spare time, she translates novels, writes children books and participates in archery competitions.
Gianluca M.E. Papeo
Claudio Pari has worked at L’Oréal since 1984, after obtaining his degree in Chemistry with a specialization on Analytic Chemistry at the University of Turin. He spent his entire professional career at L’Oréal until June 2021.
At l’Oréal Italia he was Scientific and Technical Regulatory Director before moving to Paris at l’Oréal France as World Technical-Regulatory Director.
In 2012, he was appointed Vice President Asia Pacific for Security and Regulatory Affairs based in Shanghai.
From 2016 to 2020, he finished his career in Paris as World Director of Regulatory Affairs.
During his professional career, he was vice president of the technical committee of Cosmetica Italia president of the cosmetic group of EUCCC (European Chamber of Commerce of China), member of numerous working groups at Cosmetics Europe and president of the China Task Force.
Currently, he is an independent professor and consultant on different subjects such as Regulatory Cosmetics and Asiatic Culture and Geopolitical affairs.
María Pellín Amorós
Maria Jose Lopez
Nuria Caturla Cernuda
Since her graduation, she has worked in different areas of the Personal Care products industry. She is specialized in Cosmetic Products Regulatory Affairs and works as a Safety Assessor for Cosmetic Products for several companies in the European Union.
She has participated in developing several regulatory strategies that have successfully ended with the registration of an innovative substances or products.
She provides Regulatory support and science-based solutions to international R&D and Personal Care companies as a Toxicologist and Regulatory affairs expert.
She has collaborated as well with different institutions as a lecturer on these matters in post graduate courses and writing legal articles in informational publications for the cosmetic industry.
María Matabuena de Yzaguirre
She graduated in Biological Sciences, completed her PhD in Cellular Biology and Genetics and was a professor and researcher at the Autonoma University of Madrid, participating in both national and international research projects, funded by the Carlos III Health Institute, the Ministry of Science and Technology, the European Regional Development Fund and the European Commission, among others, which led to various publications in specialized journals.
In 2010, she was part of the teaching and research staff of the University of Alcalá de Henares, in the Department of Plant Biology, where he carried out the Scientific Direction of a research project for the development of new products with regenerating properties.
In 2014, she consolidated her professional career in the business world as Laboratory Director and R&D of Invitrotecnia S. L. In 2018, she constitutes ILICE EFFITECH, a Spin-off of the Miguel Hernández University, dedicated to the development and commercialization of Strategic Bioactive Ingredients. He currently coordinates the INVIEW-LABS specialized R&D laboratory platform for the development and evaluation of the efficacy and safety of products for human use.
She has participated as a trainer in all editions of the Course of Experts in Evaluation of Cosmetic Products organized by STANPA and San Pablo CEU, and for a few years, she has been part of the teaching staff of the Master’s Degree in Cosmetics and Dermopharmacy at CESIF.
Marta García Escolano
After finishing a Master in Biomedicine at the University of Alicante, she worked as a researcher at the Neuroscience Institute of Alicante. During her PhD, she studied the involvement of four genes in the initiation and progression of breast cancer at the University General Hospital of Alicante. In 2018, she moved to New York to collaborate in the characterization of a new molecule with antitumor activity at the Memorial Sloan Kettering Cancer Center. In 2019 she obtained her PhD in Experimental Science and Biomedicine and in early 2020 she moved towards Cosmetic Industry joining Prospera Biotech. Currently, as Project Manager, she is working to take to the market the last advances in skin neurosensory research.
Philipp holds a Master of Business Administration (MBA) Degree from the Middlesex University London (U.K.). He also studied Management and Economics at the University of Innsbruck (Austria).
Last modified: October 28, 2021